beta

ALDR

Alder BioPharmaceuticals Inc.

Aldr

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Alder BioPharmaceuticals Inc is a biotechnology company. It is engaged in the discovery, development, and commercialization of therapeutic antibodies addresses diseases with limited medical options. The company operates across the US and Australia.

Market Cap: 1.15 Billion

Primary Exchange: NASDAQ Global Market

Website: http://www.alderbio.com

Shares Outstanding: 67.8 Million

Float: 67.3 Million

Dividend: 0.0 (0.0%)

Beta: 2.861837

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 6.22 Million

Ethical Flags

Animal testing

Longest drawdown: 1221 trading days

From: 2015-06-30 To: 2019-10-11

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud